Confirmation of Ath26 locus on chromosome 17 and identification of Cyp4f13 as an atherosclerosis modifying gene
- 1 July 2019
- journal article
- research article
- Published by Elsevier in Atherosclerosis
- Vol. 286, 71-78
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (P01HL029582)
- American Heart Association (#15sdg25310009)
This publication has 23 references indexed in Scilit:
- Genetic‐Genomic Replication to Identify Candidate Mouse Atherosclerosis Modifier GenesJournal of the American Heart Association, 2013
- A simple and sensitive enzymatic method for cholesterol quantification in macrophages and foam cellsJournal of Lipid Research, 2010
- Human cytochrome P450 4F11: Heterologous expression in bacteria, purification, and characterization of catalytic functionArchives of Biochemistry and Biophysics, 2010
- Cytochromes P450 from family 4 are the main omega hydroxylating enzymes in humans: CYP4F3B is the prominent player in PUFA metabolismJournal of Lipid Research, 2008
- Cytochrome P450 omega hydroxylase (CYP4) function in fatty acid metabolism and metabolic diseasesBiochemical Pharmacology, 2008
- Sex Specific Gene Regulation and Expression QTLs in Mouse Macrophages from a Strain IntercrossPLOS ONE, 2008
- The Problem of Passenger Genes in Transgenic MiceArteriosclerosis, Thrombosis, and Vascular Biology, 2007
- Atherosclerosis Susceptibility Loci Identified From a Strain Intercross of Apolipoprotein E–Deficient Mice via a High-Density Genome ScanArteriosclerosis, Thrombosis, and Vascular Biology, 2006
- Expression and characterization of human cytochrome P450 4F11: Putative role in the metabolism of therapeutic drugs and eicosanoidsToxicology and Applied Pharmacology, 2004
- Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cellsCell, 1992